Updates

20th Annual General Meeting – 2026 Vilin Bio Med Limited successfully convened its 20th Annual General Meeting on 2 September 2026 at 3:00 PM, bringing together the Company’s management and shareholders to review the Company’s performance and key developments during the year. The Annual General Meeting provided an important platform for shareholder engagement and transparent […]

Vilin Bio Med Limited is pleased to announce the signing of a Memorandum of Understanding (MoU) with Ideal Pharma B.V., The Netherlands, on 28 July 2026 in Heerlen, The Netherlands. The collaboration marks an important step in the Company’s strategy to strengthen its presence in the European pharmaceutical market. The strategic collaboration aims to combine

It was a pleasure meeting with the Founder & CEO of Apozeal Pharmaceuticals Inc., Levittown, Pennsylvania, USA. Our discussions focused on exploring opportunities for strategic collaboration in pharmaceutical development, manufacturing, and expanding access to high-quality healthcare solutions across global markets. At Vilin Bio Med Limited, we remain committed to building strong international partnerships that accelerate

Building bridges for better healthcare, Expanding horizons to GCC region It was a genuine pleasure to welcome Dr. Ahmed Al Mohanadi, Chief Executive Officer of QLife Pharma, to Mumbai for a warm and forward-looking meeting between our teams. A team led by DR Madhu Sudhan Reddy Yadamakanti Managing Director Vilin Bio Med Limited participated in

Founded in 2005, VILIN BIO MED LIMITED has steadily evolved from a regional pharmaceutical formulations manufacturer into an emerging integrated healthcare company with expanding manufacturing capabilities, international ambitions, and increasing investor visibility in India’s SME pharmaceutical ecosystem. Headquartered in Hyderabad, the company continues to strengthen its presence through diversified pharmaceutical solutions, infrastructure expansion, and a